Gregori Andrea, Galli Stefano, Kartalas Ioannis Goumas, Scieri Francesco, Stener Silvio, Incarbone Giacomo Piero, Gaboardi Franco
Department of Urologic Surgery, Luigi Sacco University Medical Center, Milan, Italy.
J Urol. 2008 May;179(5):1902-6. doi: 10.1016/j.juro.2008.01.015. Epub 2008 Mar 18.
We evaluated whether transrectal ultrasound guided ProACT system implantation in patients under local anesthesia and with stress urinary incontinence after radical prostatectomy is feasible in a day hospital setting, and is safe and well tolerated.
The procedure was used in 11 consecutive patients (mean age 69.9 years) with stress urinary incontinence after undergoing radical prostatectomy between November 2006 and July 2007. The ProACT system was implanted with a transrectal ultrasound guided procedure after administration of local anesthesia (40 ml ropivacaine 7.5 mg/ml) in perineal skin, subcutaneous tissue, pelvic diaphragm and laterally to the anastomosis. During surgery any reason for discomfort was collected. Pain was evaluated with the visual analogue scale, Numeric Pain Intensity Scale and Simple Descriptive Pain Intensity Scale. Transrectal ultrasound was performed 7 days after surgery to exclude device migrations due to early patient mobilization.
The ProACT systems were successfully implanted in all patients under local anesthesia without any need for general anesthesia, and without perioperative surgical or anesthesia related complications. Subjective discomfort was minimal. Mean visual analogue scale was 13 mm (range 0 to 28). Mean Numeric Pain Intensity Scale was 1.4 points (range 0 to 4). On the Simple Descriptive Pain Intensity Scale 4 patients (36.3%) reported no pain, 5 (45.5%) reported mild pain and 2 (18.2%) reported moderate pain. Discharge from the hospital was possible for all patients after 6 hours. All transrectal ultrasound performed after 7 days excluded balloon migrations.
Transrectal ultrasound guided ProACT system implantation with the patient under local anesthesia only is feasible, safe, well tolerated and may be performed as a day surgery procedure.
我们评估了在日间医院环境下,对根治性前列腺切除术后出现压力性尿失禁的患者在局部麻醉下经直肠超声引导植入ProACT系统是否可行,以及该方法是否安全且耐受性良好。
2006年11月至2007年7月期间,对11例(平均年龄69.9岁)根治性前列腺切除术后出现压力性尿失禁的患者采用了该手术方法。在会阴皮肤、皮下组织、盆底肌及吻合口外侧给予局部麻醉(40ml浓度为7.5mg/ml的罗哌卡因)后,经直肠超声引导植入ProACT系统。手术过程中收集任何不适原因。采用视觉模拟评分法、数字疼痛强度评分法和简单描述性疼痛强度评分法评估疼痛情况。术后7天进行经直肠超声检查,以排除因患者早期活动导致的装置移位。
所有患者均在局部麻醉下成功植入ProACT系统,无需全身麻醉,且无围手术期手术或麻醉相关并发症。主观不适极小。视觉模拟评分法平均为13mm(范围0至28)。数字疼痛强度评分法平均为1.4分(范围0至4)。在简单描述性疼痛强度评分法中,4例(36.3%)患者报告无疼痛,5例(45.5%)报告轻度疼痛,2例(18.2%)报告中度疼痛。所有患者术后6小时均可出院。术后7天进行的所有经直肠超声检查均排除了球囊移位。
仅在局部麻醉下经直肠超声引导植入ProACT系统是可行的、安全的、耐受性良好的,并且可以作为日间手术进行。